MOUNTAIN VIEW, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will provide an update and report financial results for the first quarter ended March 31, 2015 after the NASDAQ Market closes on Tuesday, May 5, 2015. The company will conduct a conference call and an audio webcast at 4:30 pm EDT the same day.

Date: May 5, 2015 Time: 4:30 PM ET Listen via Internet: Schedule this webcast into MS-Outlook calendar (click open when prompted):

Toll-free: (888) 771-4371 Telephone: (847) 585-4405

A webcast replay will be available on the VIVUS website for 30 days.

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2014 as filed on February 25, 2015 and periodic reports filed with the Securities and Exchange Commission.
CONTACT: VIVUS, Inc.         Dana B. Shinbaum (Corporate Development & Investor Relations)         650-934-5200         The Trout Group         Brian Korb (Managing Director)         646-378-2923

VIVUS logo